Native Top-Down Mass Spectrometry and Ion Mobility Spectrometry of the Interaction of Tau Protein with a Molecular Tweezer Assembly Modulator.
Electron capture dissociation
Electrospray ionization
Native mass spectrometry
Tau
Top-down mass spectrometry
Tweezer
Journal
Journal of the American Society for Mass Spectrometry
ISSN: 1879-1123
Titre abrégé: J Am Soc Mass Spectrom
Pays: United States
ID NLM: 9010412
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
29
04
2018
accepted:
03
07
2018
revised:
03
07
2018
pubmed:
1
8
2018
medline:
19
3
2019
entrez:
1
8
2018
Statut:
ppublish
Résumé
Native top-down mass spectrometry (MS) and ion mobility spectrometry (IMS) were applied to characterize the interaction of a molecular tweezer assembly modulator, CLR01, with tau, a protein believed to be involved in a number of neurodegenerative disorders, including Alzheimer's disease. The tweezer CLR01 has been shown to inhibit aggregation of amyloidogenic polypeptides without toxic side effects. ESI-MS spectra for different forms of tau protein (full-length, fragments, phosphorylated, etc.) in the presence of CLR01 indicate a primary binding stoichiometry of 1:1. The relatively high charging of the protein measured from non-denaturing solutions is typical of intrinsically disordered proteins, such as tau. Top-down mass spectrometry using electron capture dissociation (ECD) is a tool used to determine not only the sites of post-translational modifications but also the binding site(s) of non-covalent interacting ligands to biomolecules. The intact protein and the protein-modulator complex were subjected to ECD-MS to obtain sequence information, map phosphorylation sites, and pinpoint the sites of inhibitor binding. The ESI-MS study of intact tau proteins indicates that top-down MS is amenable to the study of various tau isoforms and their post-translational modifications (PTMs). The ECD-MS data point to a CLR01 binding site in the microtubule-binding region of tau, spanning residues K294-K331, which includes a six-residue nucleating segment PHF6 (VQIVYK) implicated in aggregation. Furthermore, ion mobility experiments on the tau fragment in the presence of CLR01 and phosphorylated tau reveal a shift towards a more compact structure. The mass spectrometry study suggests a picture for the molecular mechanism of the modulation of protein-protein interactions in tau by CLR01. Graphical Abstract ᅟ.
Identifiants
pubmed: 30062477
doi: 10.1007/s13361-018-2027-6
pii: 10.1007/s13361-018-2027-6
pmc: PMC6320309
mid: NIHMS1502082
doi:
Substances chimiques
Bridged-Ring Compounds
0
CLR01 compound
0
Organophosphates
0
tau Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16-23Subventions
Organisme : National Institutes of Health
ID : S10OD018504
Organisme : NCRR NIH HHS
ID : S10 RR028893
Pays : United States
Organisme : National Institute of General Medical Sciences
ID : R01GM103479
Organisme : NIA NIH HHS
ID : RF1 AG054000
Pays : United States
Organisme : National Institute on Aging
ID : RF1AG054000
Organisme : National Institutes of Health
ID : S10RR028893
Organisme : NIGMS NIH HHS
ID : R01 GM103479
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG050721
Pays : United States
Organisme : NIH HHS
ID : S10 OD018504
Pays : United States
Organisme : National Institute on Aging
ID : R01AG050721
Commentaires et corrections
Type : ErratumIn
Références
Trends Neurosci. 2001 Apr;24(4):219-24
pubmed: 11250006
J Biol Chem. 2001 Dec 21;276(51):48165-74
pubmed: 11606569
J Am Chem Soc. 2002 Jan 30;124(4):672-8
pubmed: 11804498
J Neurosci Res. 2002 Sep 1;69(5):567-77
pubmed: 12210822
Angew Chem Int Ed Engl. 2003 Mar 17;42(11):1210-50
pubmed: 12645054
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9034-8
pubmed: 12853572
J Neurosci. 2003 Aug 6;23(18):6972-81
pubmed: 12904458
FEBS Lett. 2006 May 22;580(12):2922-7
pubmed: 16529745
J Am Chem Soc. 2006 Nov 15;128(45):14432-3
pubmed: 17090006
Anal Chem. 2007 Mar 1;79(5):1778-84
pubmed: 17375392
J Am Soc Mass Spectrom. 2007 Jul;18(7):1206-16
pubmed: 17434746
J Am Soc Mass Spectrom. 2008 Aug;19(8):1199-208
pubmed: 18565758
J Am Chem Soc. 2008 Jul 30;130(30):9824-8
pubmed: 18605724
Anal Chem. 2009 Jan 1;81(1):248-54
pubmed: 19117454
J Am Soc Mass Spectrom. 2010 Dec;21(12):1966-8
pubmed: 20843701
Neurochem Int. 2011 Mar;58(4):458-71
pubmed: 21215781
Int J Mass Spectrom. 2011 Mar 1;300(2-3):118-122
pubmed: 21499519
Angew Chem Int Ed Engl. 2011 May 16;50(21):4808-42
pubmed: 21538733
Anal Chem. 2011 Jul 15;83(14):5598-606
pubmed: 21612283
J Mol Neurosci. 2011 Nov;45(3):425-31
pubmed: 21785996
J Am Chem Soc. 2011 Oct 26;133(42):16958-69
pubmed: 21916458
Acc Chem Res. 2013 Apr 16;46(4):1010-9
pubmed: 22853652
J Am Chem Soc. 2012 Oct 10;134(40):16607-13
pubmed: 22998648
Lancet Neurol. 2013 Jun;12(6):609-22
pubmed: 23684085
Curr Pharm Des. 2014;20(15):2469-83
pubmed: 23859557
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4884-8
pubmed: 2455299
J Biol Chem. 2014 Apr 11;289(15):10727-37
pubmed: 24567327
BMC Pharmacol Toxicol. 2014 Apr 16;15:23
pubmed: 24735982
Neuron. 1989 Oct;3(4):519-26
pubmed: 2484340
J Am Soc Mass Spectrom. 2014 Dec;25(12):2060-8
pubmed: 24912433
J Phys Chem B. 2015 Apr 9;119(14):4831-41
pubmed: 25751170
J Am Soc Mass Spectrom. 2016 Mar;27(3):520-31
pubmed: 26589699
Nat Rev Neurol. 2016 Jan;12(1):15-27
pubmed: 26635213
J Am Soc Mass Spectrom. 2016 May;27(5):786-94
pubmed: 26860087
J Am Soc Mass Spectrom. 2016 Jun;27(6):975-90
pubmed: 27052739
J Am Soc Mass Spectrom. 2016 Jun;27(6):952-65
pubmed: 27080007
Chem Commun (Camb). 2016 Oct 15;52(76):11318-34
pubmed: 27546596
J Am Soc Mass Spectrom. 2017 Jan;28(1):21-28
pubmed: 27730522
J Am Soc Mass Spectrom. 2017 Jan;28(1):5-13
pubmed: 27909974
J Am Chem Soc. 2017 Apr 26;139(16):5640-5643
pubmed: 28406616
J Am Soc Mass Spectrom. 2017 Sep;28(9):1805-1814
pubmed: 28685494
J Am Soc Mass Spectrom. 2017 Sep;28(9):1815-1822
pubmed: 28755259
Lancet. 1986 Nov 8;2(8515):1098
pubmed: 2877247
Nat Chem. 2018 Feb;10(2):139-148
pubmed: 29359744
Angew Chem Int Ed Engl. 2018 Mar 12;57(12):3099-3103
pubmed: 29368447
Biochim Biophys Acta Proteins Proteom. 2018 May - Jun;1866(5-6):668-679
pubmed: 29630971
J Am Soc Mass Spectrom. 2018 Sep;29(9):1870-1880
pubmed: 29951842
J Cell Biol. 1986 Dec;103(6 Pt 2):2739-46
pubmed: 3098742
Brain Res. 1986 Dec;387(3):271-80
pubmed: 3103857
Proc Natl Acad Sci U S A. 1988 Jun;85(11):4051-5
pubmed: 3131773
Bioconjug Chem. 1995 Nov-Dec;6(6):644-65
pubmed: 8608177
Mass Spectrom Rev. 1997 Jan-Feb;16(1):1-23
pubmed: 9414489